These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11226767)

  • 1. Methadone analgesia in cancer pain patients on chronic methadone maintenance therapy.
    Manfredi PL; Gonzales GR; Cheville AL; Kornick C; Payne R
    J Pain Symptom Manage; 2001 Feb; 21(2):169-74. PubMed ID: 11226767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
    Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
    J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Pain Control in Terminally Ill Cancer Patients by Introducing Low-Dose Oral Methadone in Addition to Ongoing Opioid Treatment.
    Fürst P; Lundström S; Klepstad P; Runesdotter S; Strang P
    J Palliat Med; 2018 Feb; 21(2):177-181. PubMed ID: 28792784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the clinical use of methadone for cancer pain.
    Ripamonti C; Zecca E; Bruera E
    Pain; 1997 Apr; 70(2-3):109-15. PubMed ID: 9150283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous methadone in the management of chronic cancer pain: safe and effective starting doses when substituting methadone for fentanyl.
    Santiago-Palma J; Khojainova N; Kornick C; Fischberg DJ; Primavera LH; Payne R; Manfredi P
    Cancer; 2001 Oct; 92(7):1919-25. PubMed ID: 11745266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit.
    Peirano GP; Mammana GP; Bertolino MS; Pastrana T; Vega GF; Russo J; Varela G; Vignaroli E; Ruggiero R; Armesto A; Camerano G; Dran G
    Support Care Cancer; 2016 Aug; 24(8):3551-6. PubMed ID: 27022964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid-sparing effect of diclofenac in cancer pain.
    Mercadante S; Sapio M; Caligara M; Serretta R; Dardanoni G; Barresi L
    J Pain Symptom Manage; 1997 Jul; 14(1):15-20. PubMed ID: 9223838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methadone as an analgesic for patients with chronic pain in methadone maintenance treatment programs (MMTPs).
    Blinderman CD; Sekine R; Zhang B; Nillson M; Shaiova L
    J Opioid Manag; 2009; 5(2):107-14. PubMed ID: 19507807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-controlled analgesia with oral methadone in cancer pain: preliminary report.
    Mercadante S; Sapio M; Serretta R; Caligara M
    Ann Oncol; 1996 Aug; 7(6):613-7. PubMed ID: 8879376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone treatment of chronic non-malignant pain and opioid dependence--a long-term follow-up.
    Rhodin A; Grönbladh L; Nilsson LH; Gordh T
    Eur J Pain; 2006 Apr; 10(3):271-8. PubMed ID: 15972261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone titration in opioid-resistant cancer pain.
    Scholes CF; Gonty N; Trotman IF
    Eur J Cancer Care (Engl); 1999 Mar; 8(1):26-9. PubMed ID: 10362950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of methadone in cancer pain treatment--a review.
    Leppert W
    Int J Clin Pract; 2009 Jul; 63(7):1095-109. PubMed ID: 19570126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
    Zimmermann C; Seccareccia D; Booth CM; Cottrell W
    J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone is safe for treating hospitalized patients with severe pain.
    Shir Y; Rosen G; Zeldin A; Davidson EM
    Can J Anaesth; 2001 Dec; 48(11):1109-13. PubMed ID: 11744587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methadone:effective analgesia, confusion, and risk.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2005; 19(2):3-5. PubMed ID: 16061455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.